ODDB.org: Open Drug Database

Medius AG - Abevmy 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	70261	Sequence	01
Product name	Abevmy 100 mg/4 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01FG01	ATC-Description	Bevacizumab
Introduction of Sequence	03.11.2025

Composition

bevacizumabum 100 mg, trehalosum dihydricum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas, polysorbatum 20, natrii hydroxidum ad pH, acidum phosphoricum ad pH, aqua ad iniectabile q.s. ad solutionem pro 4 ml corresp. natrium 4.5 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Bevacizumab	100mg / 4ml

BAG: Active Agent	Dose
Bevacizumab	100 mg

Inactive agents
Acidum Phosphoricum ad Ph
Disodium Phosphate
Sodium Dihydrogenophosphate Dihydrate
Natrii Hydroxidum ad Ph
Polysorbatum 20
Trehalosum Dihydricum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001		216.38	254.30	A	SL	No

2026	©ywesee GmbH